April 6, 2022

Researcher Update: April 2022

In this month’s Researcher Update you’ll find information on:

CURE Epilepsy’s 2022-2023 Research Seminar Series Applications Now Being Accepted
We are excited to announce that we are now accepting applications for our 2022-2023 Research Seminar Series sponsored by the Nussenbaum-Vogelstein Family. CURE Epilepsy will provide $2,500 USD to each sponsored lectureship to offset costs associated with hosting a seminar at your institution. The deadline for applications is May 27, 2022, at 5 PM CST. Learn more here.

CURE Epilepsy Promotes Lauren Harte-Hargrove, PhD to Director, Research
CURE Epilepsy is proud to announce that Dr. Lauren Harte-Hargrove has been promoted to Director, Research. In her time at CURE Epilepsy, Dr. Harte-Hargrove has contributed significantly to CURE Epilepsy’s overall research program, communications, and especially our efforts to drive research on post-traumatic epilepsy (PTE). Her leadership of CURE Epilepsy’s ongoing PTE Initiative has been critical to its success. Please join us in congratulating Lauren! See the entire CURE Epilepsy Team here.

Abstract Submission is Now Open for AES 2022
The American Epilepsy Society has announced that abstract submission for the 2022 Annual Meeting in Nashville is now open. Abstracts must be submitted by June 8 at 12pm (noon) PT for consideration, and abstracts submitted by June 1st will be eligible for a discounted processing fee. Learn more and submit here.

OPEN Stage: IGNITE Program Funding Opportunity Webinar and Q&A – April 27
This NINDS Innovation Grants to Nurture Initial Translational Efforts (IGNITE Program) webinar will describe the program and give some tips for applying. The target audience is anyone interested in funding for translating novel small molecule or biologic therapeutics for neurological disorders. This webinar will take place on Wednesday, April 27. Learn more and register here.

Postdoctoral Fellowship Opportunity in Epilepsy Research
Apply now for a postdoctoral fellowship in the laboratory of Dr. Aristea Galanopoulou in the Saul R. Korey Department of Neurology, at Albert Einstein College of Medicine. Dr. Galanopoulou’s laboratory has special interest in epileptogenesis through the lifespan and developing better treatments for epilepsies and comorbidities. Download the instructions and guidelines here.


Related News